Akari Therapeutics
AKTX | NASDAQ
$8.05
-$0.20 (-2.42%)
Nov 2, 2026, 11:20 AM ET · Market open
Fiscal Year Period Ending | FY 2025 Dec 31, 2025 | FY 2024 Dec 31, 2024 | FY 2023 Dec 31, 2023 | FY 2022 Dec 31, 2022 | FY 2021 Dec 31, 2021 | FY 2020 Dec 31, 2020 |
|---|---|---|---|---|---|---|
PE Ratio | 0 | 0 | 0 | 0 | 0 | 0 |
PEG Ratio | 0 | 0 | 0 | 0 | 0 | 0 |
PS Ratio | n/a | n/a | n/a | n/a | n/a | n/a |
PB Ratio | 0.01 | 0.01 | -1.33 | 0.33 | 0.23 | 0.07 |
P/FCF Ratio | -0.02 | -0.02 | -0.02 | -0.03 | -0.07 | -0.04 |
P/OCF Ratio | -0.02 | -0.02 | -0.02 | -0.03 | -0.07 | -0.04 |
OCF/S Ratio | n/a | n/a | n/a | n/a | n/a | n/a |
Debt / Equity Ratio | 0.03 | 0.15 | n/a | n/a | n/a | n/a |
Quick Ratio | 0.44 | 0.15 | 0.95 | 1.15 | 1.91 | 2.79 |
Current Ratio | 0.44 | 0.15 | 0.95 | 1.15 | 1.91 | 2.79 |
Asset Turnover | n/a | n/a | n/a | n/a | n/a | n/a |
Interest Coverage | -18.20 | 88.70 | n/a | n/a | n/a | n/a |
Return on Equity | -61.06% | -89.03% | 4.37K% | -990.95% | -313.69% | -182.02% |
Return on Assets | -36.12% | -39.14% | -229.80% | -128.31% | -149.59% | -116.96% |
Return on Invested Capital | -44.99% | -63.82% | 7.34K% | -1.29K% | -309.91% | -191.61% |
Dividend Yield | n/a | n/a | n/a | n/a | n/a | n/a |
Payout Ratio | n/a | n/a | n/a | n/a | n/a | n/a |
FCF Payout Ratio | n/a | n/a | n/a | n/a | n/a | n/a |
Gross Profit Margin | n/a | n/a | n/a | n/a | n/a | n/a |
Net Profit Margin | n/a | n/a | n/a | n/a | n/a | n/a |
Pretax Profit Margin | n/a | n/a | n/a | n/a | n/a | n/a |
Operating Profit Margin | n/a | n/a | n/a | n/a | n/a | n/a |
FCF Margin | n/a | n/a | n/a | n/a | n/a | n/a |
EBITDA Margin | n/a | n/a | n/a | n/a | n/a | n/a |
Add to Watchlist
Select watchlists to add or remove AKTX